Bayer Cropscience Ltd. key Products/Revenue Segments include Insecticides, Pesticides, Herbicides, Weedicides & Fungicides, Other Operating Revenue, Scrap and Royalty Income for the year ending 31-Mar ...
Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...
Bayer BAYN-0.85%decrease; red down pointing triangle said the Federal Court of Australia closed the last pending case in the country over whether its Roundup weedkiller causes cancer, a win for ...
In the United States, Bayer will continue its multipronged strategy to significantly contain the Roundup™ litigation. Having achieved favorable outcomes in 15 of the last 22 trials, the company ...
Despite restructuring efforts, Bayer's financial outlook for 2025 remains weak, with anticipated declining earnings. Consensus estimates project $3-4 billion free cash flow for 2026-2027 ...
"In Champions ogni partita può decidere il destino di una squadra o dell'altra. Vediamo che tante grandi squadre sono in bassa classifica, alla finale mancano parecchi mesi. Noi stiamo portando ...
Video, 00:03:03Ten-man Atletico Madrid fight back to beat Leverkusen Ten-man Atletico recover to stun Leverkusen Bayer Leverkusen v Borussia M'gladbach Bayer Leverkusen v Mainz 05 Leverkusen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback